| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/08/1994 | US5292650 Aerobic culture |
| 03/08/1994 | US5292648 Microorganism of genus eupenicillium |
| 03/08/1994 | US5292647 Strain of streptomyces for producing avermectins and processes therewith |
| 03/08/1994 | US5292535 Hyperosmotic solutions for isonatremic resuscitation |
| 03/08/1994 | US5292534 Sustained release composition and method utilizing xanthan gum and an active ingredient |
| 03/08/1994 | US5292531 Inhibiting bacterial disease; tetrahydroabietic acid and salts and hydrogenated rosin and salts |
| 03/08/1994 | US5292528 Oral Composition |
| 03/08/1994 | US5292521 And an organic acid or salt |
| 03/08/1994 | US5292518 Prolonged-release drug tablet formulations |
| 03/08/1994 | US5292513 Method for nonspecific cellular immune stimulation |
| 03/08/1994 | US5292512 Cosmetic or pharmaceutical composition containing microspheres of polymers or of fatty substances filled with at least one active product |
| 03/08/1994 | US5292505 HIV treatment |
| 03/08/1994 | US5292498 Method of treating lung disease with uridine triphosphates |
| 03/08/1994 | US5292497 Method of reducing chemotherapy toxicity using (methylaminopropylamino)propyl dihydrogen phosphorothioate |
| 03/08/1994 | US5291896 Cardiac output probe assembly |
| 03/08/1994 | CA2105630A1 Method of treating viral infections |
| 03/08/1994 | CA1327601C Phenoxyalkylcarboxylic acid derivatives and process for their preparations |
| 03/08/1994 | CA1327595C Biologically active carboxylic acid esters |
| 03/08/1994 | CA1327589C 1-[(2-fluorophenyl)(4-fluorophenyl)phenylmethyl]- 1h-imidazole, its obtention and its use in the preparation of antifungal compositions |
| 03/08/1994 | CA1327588C Leukotriene antagonists |
| 03/08/1994 | CA1327586C Cycloalkane¬1,2-c:4,3-c'|dipyrazoles |
| 03/08/1994 | CA1327582C 1,4-dihydropyridine derivative named (-){[(amino-2 ethoxy)-2 ethoxy] methyl}-2 (dichloro-2,3 phenyl)-4 ethoxycarbonyl-3 methoxycarbonyl-5 methyl-6 dihydro-1,4 pyridine; process for preparing the same and pharmaceutical compositions containing said derivative |
| 03/08/1994 | CA1327581C Benzopyrrolidinone derivatives; process for preparing the same and pharmaceutical compositions containing them |
| 03/08/1994 | CA1327580C 7-(3-amino-1-pyrrolidinyl)-1-cyclopropyl-6-fluoro-1, 4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid derivatives |
| 03/08/1994 | CA1327579C Anti-histaminic compositions containing n-heterocyclyl-4-piperidinamines |
| 03/08/1994 | CA1327577C 6-phenyl-3-(piperazinylalkyl)-2,4(1h,3h)- pyrimidinedione derivatives, their preparation and their application in therapy |
| 03/08/1994 | CA1327576C Phenoxyacetic acid amide derivatives and their use in the treatment of obesity and related conditions |
| 03/08/1994 | CA1327575C 1,4-benzoxazine and 1,4-benzothiazine derivatives and process for their preparation |
| 03/08/1994 | CA1327573C Pyridazinamine derivatives |
| 03/08/1994 | CA1327572C Imidazodiazepine derivatives |
| 03/08/1994 | CA1327570C Triazolo-thieno- and benzodiazepine derivatives as platelet activating factor antagonists |
| 03/08/1994 | CA1327569C Hylan preparation and method of recovery thereof from animal tissues |
| 03/08/1994 | CA1327530C Device and composition for treatment of the gums |
| 03/08/1994 | CA1327529C Dental composition and a process for the preparation thereof |
| 03/08/1994 | CA1327525C Treatment of glaucoma using phosphodiesterase inhibitors |
| 03/08/1994 | CA1327524C Prostaglandins for use in medicine |
| 03/05/1994 | CA2105530A1 Pharmaceutical composition for topical application to the eye for treating increased intraocular pressure |
| 03/04/1994 | CA2484248A1 Excitatory amino acid receptor antagonists |
| 03/04/1994 | CA2105338A1 Furanoindoline derivatives |
| 03/03/1994 | WO1994004702A2 Improved detection and therapy of lesions with biotin/avidin conjugates |
| 03/03/1994 | WO1994004701A1 Process for producing optically active 1,4-dihydropyridine compound |
| 03/03/1994 | WO1994004694A1 Endothelial lineage specific transcriptional regulatory element from tek |
| 03/03/1994 | WO1994004671A1 Methods and therapeutic compositions for treating cystic fibrosis |
| 03/03/1994 | WO1994004614A1 Metal-mediated cross-coupling with ring-metalated porphyrins |
| 03/03/1994 | WO1994004596A1 Crosslinked polymeric ammonium salts |
| 03/03/1994 | WO1994004554A1 ANDROST-4-ENO[4,5-b]PYRROLE DERIVATIVES AND PROCESS FOR THEIR PREPARATION |
| 03/03/1994 | WO1994004552A1 Opioid receptor genes |
| 03/03/1994 | WO1994004545A1 Triantennary cluster glycosides, their preparation and use |
| 03/03/1994 | WO1994004541A2 Protein kinase inhibitors and related compounds combined with taxol |
| 03/03/1994 | WO1994004540A1 27-hydroxyrapamycin and derivatives thereof |
| 03/03/1994 | WO1994004536A1 Ethynyl alanine amino diol compounds having a piperazinyl-terminated group or a piperazinyl-alkylamino-terminated group for treatment of hypertension |
| 03/03/1994 | WO1994004535A1 Trifluoromethylpyrroloindole carboxylic ester derivative and process for producing the same |
| 03/03/1994 | WO1994004534A1 Tetrahydropyrroloindole derivative, process for producing the same, and intermediates therefor |
| 03/03/1994 | WO1994004533A1 Condensed indole derivatives as 5ht2c and 5ht2b antagonists |
| 03/03/1994 | WO1994004532A1 3-oxo-pyrido(1,2-a^_)benzimidazole-4-carboxyl and 4-oxo-azepino(1,2-a^_)benzimidazole-5-carboxyl derivatives useful in treating central nervous system disorders |
| 03/03/1994 | WO1994004531A1 Novel 2-substituted indane-2-mercaptoacetylamide tricyclic derivatives useful as inhibitors of enkephalinase |
| 03/03/1994 | WO1994004520A1 Ascofuranone, and hypolipidemic agent, hypoglycemic agent and glycation inhibitor each containing ascofuranone derivative as active ingredient |
| 03/03/1994 | WO1994004518A1 Morpholino/thiomorpholino-terminated alkylamino ethynyl alanine amino diol compounds as renin inhibitors |
| 03/03/1994 | WO1994004513A1 Pharmaceutically active diketopiperazines |
| 03/03/1994 | WO1994004512A1 Pharmaceutically active diketopiperazines |
| 03/03/1994 | WO1994004508A1 Imidazolyl/benzimidazolyl-terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension |
| 03/03/1994 | WO1994004503A1 Pyridinyl/quinolinyl-terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension |
| 03/03/1994 | WO1994004500A1 Cyanoguanidines as potassium channel blockers |
| 03/03/1994 | WO1994004499A1 Cyanoguanidines as potassium channel blockers |
| 03/03/1994 | WO1994004498A1 3-hydroxypyridin-4-one derivatives as chelating agents |
| 03/03/1994 | WO1994004496A1 Substituted benzylamino nitrogen containing non-aromatic heterocycles |
| 03/03/1994 | WO1994004495A1 Piperidinyl-terminated n-(dihydroxy alkyl)-ethynyl-alanine amides for treatment of hypertension |
| 03/03/1994 | WO1994004494A1 Tachykinin antagonists |
| 03/03/1994 | WO1994004493A1 Sulfonylalkanoylamino hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
| 03/03/1994 | WO1994004492A1 Hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
| 03/03/1994 | WO1994004491A1 N-(alkanoylamino-2-hydroxypropyl)-sulfonamides useful as retroviral protease inhibitors |
| 03/03/1994 | WO1994004484A1 Nitric esters of derivatives of the 2-(2,6-di-halophenylamino)phenylacetic acid and process for their preparation |
| 03/03/1994 | WO1994004301A1 Quick-change tool holder with center-height adjustment mechanism |
| 03/03/1994 | WO1994004222A2 Adjunctive photodynamic therapy for treating cardiovascular disease |
| 03/03/1994 | WO1994004186A1 Homeopathic compositions for the treatment of viral and metabolic diseases |
| 03/03/1994 | WO1994004185A2 Method of inhibiting reduction of disulfide bonds |
| 03/03/1994 | WO1994004183A1 Methods for effecting a prolonged reduction in measurable fat content and medicaments for use therein |
| 03/03/1994 | WO1994004177A1 Methods useful in endotoxin prophylaxis and therapy |
| 03/03/1994 | WO1994004175A1 Hgf production promoter |
| 03/03/1994 | WO1994004168A1 Anti-cancer therapeutic compositions containing whey protein concentrate |
| 03/03/1994 | WO1994004165A1 Antiangiogenic oligomers |
| 03/03/1994 | WO1994004164A1 Antiproliferative oligomers |
| 03/03/1994 | WO1994004163A1 Novel glucan preparation |
| 03/03/1994 | WO1994004162A1 Astragalus polysaccharide immunomodulators |
| 03/03/1994 | WO1994004161A1 Use of inhibitors of vacuolar-type h+ atpases |
| 03/03/1994 | WO1994004160A1 Treatment of human viral infections |
| 03/03/1994 | WO1994004159A2 Treatment of cancer with azt and alkylating or intercalating agents |
| 03/03/1994 | WO1994004158A1 Use of ribose in the preparation of a drug for use in the treatment of decrease in body performance, in particular organ insufficiency |
| 03/03/1994 | WO1994004157A1 Transdermal application agent containing 3-keto-desogestrel |
| 03/03/1994 | WO1994004156A1 Antiprogestogen containing contraceptives |
| 03/03/1994 | WO1994004155A1 Dehydroepiandrosterone therapy for the treatment of eye disorders |
| 03/03/1994 | WO1994004154A1 ENANTIOMERICALLY PURE β-D-DIOXOLANE-NUCLEOSIDES |
| 03/03/1994 | WO1994004153A1 Use of angiotensin ii antagonists for the treatment of hyperlipidaeme |
| 03/03/1994 | WO1994004151A1 Compositions of substituted azaspiranes and methods of treating psoriasis therewith |
| 03/03/1994 | WO1994004150A1 Methods of treating psoriasis employing substituted azaspiranes |
| 03/03/1994 | WO1994004149A1 Use of macrolide compounds for the treatment of skin diseases |
| 03/03/1994 | WO1994004148A1 Use of macrolide compounds for the treatment of reversible obstructive airways disease |
| 03/03/1994 | WO1994004147A1 Method for destroying or inhibiting growth of unwanted cells or tissues |
| 03/03/1994 | WO1994004145A1 Treatment of human viral infections |
| 03/03/1994 | WO1994004143A1 Substituted hydrindanes for the treatment of angiogenesis-dependent diseases |